Skip Navigation
Skip to contents

J Musculoskelet Trauma : Journal of Musculoskeletal Trauma

OPEN ACCESS

Articles

Page Path
HOME > J Musculoskelet Trauma > Volume 30(3); 2017 > Article
Case Report
Oncogenic Osteomalacia with Multiple Insufficiency Fractures: A Case Report
Young-Chang Park, M.D.orcid, Joon-Oh Seo, M.D.orcid, Kyu-Hyun Yang, M.D., Ph.D.orcid
Journal of the Korean Fracture Society 2017;30(3):146-150.
DOI: https://doi.org/10.12671/jkfs.2017.30.3.146
Published online: July 21, 2017

Department of Orthopaedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Correspondence to: Kyu-Hyun Yang, M.D., Ph.D. Department of Orthopaedic Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea. Tel: +82-2-2019-3414, Fax: +82-2-573-5393, kyang@yuhs.ac
• Received: May 2, 2017   • Revised: May 27, 2017   • Accepted: May 27, 2017

Copyright © 2017 The Korean Fracture Society. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 23 Views
  • 1 Download
prev next
  • Oncogenic osteomalacia is a rare paraneoplastic syndrome, characterized by hypophosphatemia, renal phosphate wasting, osteomalacia, and multiple insufficiency fractures, as a result of the tumor. A wide excision of the causative tumor is considered as the treatment of choice, following which, a dramatic recovery is expected. Authors report a case in which the symptoms and bone mineral density were dramatically recovered after an excision of the causative tumor around the tibialis posterior muscle in oncogenic osteomalacia.
  • 1. McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years. Q J Med, 1947;16:33-46.
  • 2. Kumar R, Folpe AL, Mullan BP. Tumor-induced osteomalacia. Transl Endocrinol Metab, 2015;7:1871.
  • 3. Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed? Clin Orthop Relat Res, 2013;471:3618-3625.
  • 4. Jan de Beur SM. Tumor-induced osteomalacia. JAMA, 2005;294:1260-1267.
  • 5. Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res, 2012;27:1967-1975.
  • 6. Chong WH, Andreopoulou P, Chen CC, et al. Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res, 2013;28:1386-1398.
  • 7. Zhang J, Zhu Z, Zhong D, et al. 68Ga DOTATATE PET/CT is an accurate imaging modality in the detection of culprit tumors causing osteomalacia. Clin Nucl Med, 2015;40:642-646.
  • 8. Andreopoulou P, Dumitrescu CE, Kelly MH, et al. Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res, 2011;26:1295-1302.
  • 9. Umphrey LG, Whitaker MD, Bosch EP, Cook CB. Clinical and bone density outcomes of tumor-induced osteomalacia after treatment. Endocr Pract, 2007;13:458-462.
Fig. 1

Spine simple x-ray lateral view shows that vertebral height of T10, 11, 12, L1, and 2 decreased slightly (A) and magnetic resonance imaging T1-weighted enhanced image shows multiple compression fracture (B).

jkfs-30-146-g001.jpg
Fig. 2

Whole body bone scan shows multifocal bony uptakes in the bilateral ribs, pelvis, femoral neck, knee, and ankle. RT: right, LT: left.

jkfs-30-146-g002.jpg
Fig. 3

Insufficiency fracture of the femoral neck. A lucent line (arrow) is called a Looser's zone or pseudofracture.

jkfs-30-146-g003.jpg
Fig. 4

(A, B) Tumor localization. Causative tumor (arrows) was found on the left lower leg by Octreoscan. (C) Magnetic resonance imaging T2-weighted image shows 4.5×2.0×2.0-cm-sized soft tissue tumor located at the tibialis posterior muscle belly. Tumor had a round, well-defined margin with heterogeneous signal intensity. RT: right.

jkfs-30-146-g004.jpg
Fig. 5

Intraoperative image. Tumor was excised completely.

jkfs-30-146-g005.jpg
Fig. 6

Bone mineral density (BMD) change. Compared to the preoperative status, BMD and Z-score at 1 year and six months follow-up after surgery showed good recovery. BMC: bone mineral content.

jkfs-30-146-g006.jpg
Table 1

Laboratory Findings in Oncogenic Osteomalcia

jkfs-30-146-i001.jpg
Variable Oncogenic osteomalacia Case Reference range
Initial visit Preoperative POD 1 day POD 1 week
Phosphorus (mg/dl) 1.7* 1.9* 3.5 3.7 2.9-4.6
25(OH)D (ng/ml) NL or ↓ 11.1* 12.1* - 16.5* 30-100
1,25(OH)2D (pg/ml) ↓ or NL - 18.79 - 278.62* 19.6-54.3
Alkaline phosphatase (IU/L) 172* 215* 201* 220* 44-99
PTH (pg/ml) NL or ↑ 118.3* 48 - - 15-65
Calcium (mg/dl) NL 8.8 8.9 8.6 8.8 8.5-10.1
FGF-23 (RU/ml) - 608* - 72 <180

*Abnormal laboratory findings. Serum phosphate and FGF-23 levels were normalized 1 week after excision of phosphaturic mesenchymal tumor. POD: postoperative day, PTH: parathyroid hormone, FGF-23: fibroblast growth factor-23, NL: normal.

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  

      • Cite
        CITE
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Oncogenic Osteomalacia with Multiple Insufficiency Fractures: A Case Report
        J Korean Fract Soc. 2017;30(3):146-150.   Published online July 31, 2017
        Close
      • XML DownloadXML Download
      Figure
      • 0
      • 1
      • 2
      • 3
      • 4
      • 5
      We recommend
      Oncogenic Osteomalacia with Multiple Insufficiency Fractures: A Case Report
      Image Image Image Image Image Image
      Fig. 1 Spine simple x-ray lateral view shows that vertebral height of T10, 11, 12, L1, and 2 decreased slightly (A) and magnetic resonance imaging T1-weighted enhanced image shows multiple compression fracture (B).
      Fig. 2 Whole body bone scan shows multifocal bony uptakes in the bilateral ribs, pelvis, femoral neck, knee, and ankle. RT: right, LT: left.
      Fig. 3 Insufficiency fracture of the femoral neck. A lucent line (arrow) is called a Looser's zone or pseudofracture.
      Fig. 4 (A, B) Tumor localization. Causative tumor (arrows) was found on the left lower leg by Octreoscan. (C) Magnetic resonance imaging T2-weighted image shows 4.5×2.0×2.0-cm-sized soft tissue tumor located at the tibialis posterior muscle belly. Tumor had a round, well-defined margin with heterogeneous signal intensity. RT: right.
      Fig. 5 Intraoperative image. Tumor was excised completely.
      Fig. 6 Bone mineral density (BMD) change. Compared to the preoperative status, BMD and Z-score at 1 year and six months follow-up after surgery showed good recovery. BMC: bone mineral content.
      Oncogenic Osteomalacia with Multiple Insufficiency Fractures: A Case Report

      Laboratory Findings in Oncogenic Osteomalcia

      Variable Oncogenic osteomalacia Case Reference range
      Initial visit Preoperative POD 1 day POD 1 week
      Phosphorus (mg/dl) 1.7* 1.9* 3.5 3.7 2.9-4.6
      25(OH)D (ng/ml) NL or ↓ 11.1* 12.1* - 16.5* 30-100
      1,25(OH)2D (pg/ml) ↓ or NL - 18.79 - 278.62* 19.6-54.3
      Alkaline phosphatase (IU/L) 172* 215* 201* 220* 44-99
      PTH (pg/ml) NL or ↑ 118.3* 48 - - 15-65
      Calcium (mg/dl) NL 8.8 8.9 8.6 8.8 8.5-10.1
      FGF-23 (RU/ml) - 608* - 72 <180

      *Abnormal laboratory findings. Serum phosphate and FGF-23 levels were normalized 1 week after excision of phosphaturic mesenchymal tumor. POD: postoperative day, PTH: parathyroid hormone, FGF-23: fibroblast growth factor-23, NL: normal.

      Table 1 Laboratory Findings in Oncogenic Osteomalcia

      *Abnormal laboratory findings. Serum phosphate and FGF-23 levels were normalized 1 week after excision of phosphaturic mesenchymal tumor. POD: postoperative day, PTH: parathyroid hormone, FGF-23: fibroblast growth factor-23, NL: normal.


      J Musculoskelet Trauma : Journal of Musculoskeletal Trauma
      Close layer
      TOP